synthet
biolog
applic
synthet
chemistri
biolog
broad
term
cover
engin
biolog
system
structur
function
found
natur
process
inform
manipul
chemic
produc
energi
maintain
cell
environ
enhanc
human
health
synthet
biolog
includ
technolog
dna
synthesi
assembl
fragment
dna
gene
synthesi
sometim
refer
synthet
genom
craig
venter
pioneer
area
describ
synthet
biolog
video
http
wwwyoutubecomwatch
genom
engin
includ
approach
construct
synthet
chromosom
goe
beyond
tradit
genet
engin
metabol
engin
use
manipul
metabol
pathway
correct
metabol
disord
also
appli
microorgan
produc
chemic
effici
genet
engin
synthet
biolog
devic
contribut
improv
understand
diseas
mechan
also
provid
novel
diagnost
tool
method
base
synthet
biolog
enabl
design
novel
strategi
treatment
cancer
immun
diseas
metabol
disord
infecti
diseas
well
product
cheap
drug
potenti
synthet
genom
use
expand
genet
code
design
specif
drug
synthesi
well
deliveri
activ
drug
vivo
patholog
signal
report
two
approach
synthet
biolog
topdown
bottomup
latter
relev
develop
person
medicin
provid
flexibl
construct
partial
synthet
cell
basic
build
block
desir
task
person
medicin
simpli
mean
prescript
specif
therapeut
best
suit
individu
usual
base
pharmacogenet
pharmacogenom
transcriptom
pharmacoproteom
pharmacometabolom
inform
individu
variat
patient
environment
factor
also
taken
consider
person
medicin
mean
improv
healthcar
incorpor
earli
detect
diseas
prevent
medicin
ration
drug
discoveri
develop
monitor
therapi
broad
scope
interrelationship
person
medicin
shown
figur
concept
person
medicin
system
medicin
best
way
integr
new
technolog
translat
clinic
applic
improv
healthcar
nanobiotechnolog
alreadi
help
develop
person
medicin
biolog
therapi
make
signific
contribut
person
medicin
initi
pharmacogenom
pharmacogenet
use
select
drug
alreadi
avail
sequenc
inform
provid
opportun
design
develop
new
person
medicin
shown
figur
sequenc
genom
variou
organ
provid
basi
develop
synthet
biolog
genom
sequenc
organ
blueprint
set
instruct
dictat
biolog
trait
resequenc
use
next
gener
technolog
mean
determin
variat
dna
sequenc
organ
nomin
sequenc
alreadi
known
relev
synthet
biolog
well
translat
diagnost
clinic
applic
j
craig
venter
institut
report
design
synthesi
assembl
genom
start
digit
genom
sequenc
inform
transplant
recipi
cell
creat
new
bacteri
cell
control
synthet
dna
research
built
synthet
genom
mycoplasma
mycoid
fastgrow
bacterium
millionbas
genom
stitch
togeth
shorter
stretch
dna
base
transfer
complet
genom
shell
anoth
bacterium
mycoplasma
capricolum
whose
dna
remov
transplant
genom
boot
host
cell
took
biolog
machineri
cell
divis
billion
synthet
bacteria
laboratori
dish
make
exclus
biolog
molecul
associ
mycoid
dna
cell
design
synthet
dna
sequenc
includ
watermark
sequenc
design
gene
delet
polymorph
mutat
acquir
build
process
new
cell
expect
phenotyp
properti
capabl
continu
selfrepl
synthet
bacteria
watermark
sequenc
attach
genom
inert
stretch
dna
ad
distinguish
natur
counterpart
behav
divid
laboratori
dish
like
natur
bacteria
appli
method
type
cell
research
design
synthes
dna
choic
develop
system
boot
genom
two
task
accomplish
parallel
everi
new
speci
accuraci
genet
code
import
engin
synthet
gene
j
craig
venter
institut
current
work
project
nation
institut
health
usa
novarti
vaccin
product
use
technolog
synthet
gene
mostli
assembl
use
ssdna
oligonucleotid
oligo
tend
contain
sequenc
error
purif
sourc
oligo
improv
puriti
pool
cost
discard
oligo
erras
enzym
technolog
facilit
gene
assembl
lower
cost
reduc
input
expens
use
unpurifi
oligo
reduc
error
synthet
gene
sequenc
detect
correct
mismatch
base
pair
introduc
procedur
novici
biotechlif
technolog
develop
erras
technolog
commerci
synthet
biolog
biosens
import
activ
due
myriad
cell
signal
pathway
circuit
cell
import
compon
twoway
commun
implant
engin
cell
natur
cell
bodi
exampl
synthet
biosens
transcript
biosensor
built
link
environmentrespons
promot
engin
gene
circuit
program
transcript
translat
biosensor
typic
built
link
rna
aptam
domain
rna
regulatori
domain
posttransl
biosensor
consist
membranebound
protein
receptor
trigger
signal
transduct
cascad
convent
oneway
biosens
therapeut
substanc
releas
implant
devic
genet
engin
cell
respons
program
mechan
eg
releas
insulin
accord
rise
blood
glucos
level
twoway
commun
host
enabl
construct
synthet
circuit
enabl
person
control
adjust
therapi
implant
cell
abil
control
express
target
area
within
genom
import
synthet
biologist
develop
chemicalproduc
organ
commerci
applic
transcript
activatorlik
tal
effector
technolog
two
hypervari
amino
acid
residu
repeat
recogn
bp
target
dna
recognit
sequenc
tal
effector
predict
tal
code
similar
navig
system
genom
allow
pinpoint
deliveri
function
control
element
specifi
sequenc
modular
protein
architectur
enabl
construct
artifici
effector
new
specif
central
challeng
synthet
biolog
enabl
growth
live
system
use
part
deriv
natur
design
synthes
laboratori
initi
step
toward
achiev
goal
synthet
protein
creat
function
escherichia
coli
use
socal
binari
code
method
reli
strateg
placement
polar
nonpolar
residu
team
scientist
made
million
stabli
fold
string
amino
acid
genet
sequenc
distinct
known
occur
natur
screen
synthet
protein
dozen
e
coli
strain
miss
essenti
gene
identifi
artifici
protein
could
substitut
organ
protein
molecular
machin
function
quit
well
within
live
organ
even
though
design
scratch
express
artifici
gene
found
artifici
protein
could
rescu
growth
e
coli
mutant
strain
miss
essenti
enzymecod
gene
serb
glta
ilva
fe
inform
encod
artifici
gene
come
significantli
relat
inform
encod
natur
gene
yet
end
result
live
function
microb
synthet
protein
substanti
less
activ
may
function
differ
mechan
natur
protein
replac
nonetheless
coexpress
sever
novel
protein
rescu
strain
multipl
natur
gene
delet
simultan
work
suggest
construct
artifici
genom
capabl
sustain
cell
life
feasibl
synthesi
therapeut
protein
approach
explor
yet
complex
synthet
biolog
network
oper
insid
live
cell
desir
manner
usual
control
genet
switch
capabl
process
therapeut
signal
sens
respond
environ
biomed
applic
engin
cell
need
seal
order
protect
host
immun
system
enabl
remov
complet
therapi
microencapsul
cell
transplant
establish
technolog
microencapsul
defin
cell
semiperm
biocompat
microcapsul
shield
extern
environ
allow
exchang
occur
molecular
basi
power
combin
synthet
biolog
microencapsul
open
door
novel
innov
cellbas
biomed
applic
smart
implant
drug
deliveri
system
wherea
tradit
genet
engin
haphazard
affair
synthet
biolog
impos
sens
order
process
knowledg
piec
dna
put
togeth
facilit
computeraid
design
tool
develop
synthet
biolog
enabl
arrang
atom
make
desir
chemic
could
enabl
har
vast
amount
genom
inform
creat
microb
new
metabol
pathway
sort
mix
match
approach
wherea
genet
engin
focus
individu
gene
synthet
biolog
string
togeth
seri
molecular
compon
dna
rna
protein
cell
circuit
network
synthet
biolog
versatil
genet
engin
develop
biopharmaceut
oral
vaccin
engin
stem
cell
bacteria
detect
treat
tumor
synthet
biolog
enabl
better
quantit
control
molecular
engin
techniqu
higher
throughput
predict
properti
sinc
sever
complex
diseas
caus
disord
human
metabol
elucid
underli
molecular
mechan
import
develop
effect
person
approach
treatment
system
biolog
facilit
analysi
complex
metabol
diseas
use
comput
approach
system
medicin
approach
util
data
metabol
process
reconstruct
genomescal
metabol
model
studi
function
specif
enzym
pathway
context
complet
metabol
network
reconstruct
genomescal
model
system
medicin
may
contribut
toward
develop
person
medicin
human
metabol
disord
engin
complex
biolog
pathway
provid
effici
rout
manufactur
natur
product
desir
pharmaceut
properti
eg
artemisinin
chines
herb
deriv
plant
artemisia
annua
treatment
malaria
accomplish
channel
flux
isoprenoid
pathway
specif
gene
involv
artemisinin
biosynthesi
biosynthesi
artemisin
acid
synthet
biolog
approach
led
manufactur
commerci
drug
low
cost
develop
countri
metabol
engin
approach
effici
coupl
isoprenoid
pathway
also
lead
construct
e
coli
strain
produc
high
titer
taxadien
first
commit
intermedi
biosynthesi
anticanc
drug
taxol
next
gener
sequenc
expect
advanc
understand
molecular
basi
common
diseas
pharmacophor
respons
improv
compil
refer
catalog
gene
transcript
nucleotid
variant
structur
variant
inform
gather
effort
use
synthet
biologybas
drug
discoveri
eg
translat
signal
identifi
genomewid
associ
studi
drug
target
next
gener
sequenc
also
use
directli
drug
discoveri
identifi
variant
associ
common
trait
nonhypothesi
direct
sequenc
mani
human
genom
synthet
biolog
provid
follow
advantag
convent
techniqu
drug
discoveri
develop
synthet
biolog
enabl
design
cell
screen
drug
molecul
reduc
drug
discoveri
timeexpens
metabol
pathway
precis
regul
synthet
organ
manipul
molecular
tool
parallel
recombin
e
colibas
biotechnolog
drug
product
synthet
biolog
enabl
redesign
cell
produc
desir
molecul
higher
efficaci
lower
toxic
data
accumul
advanc
sequenc
use
combin
synthet
biolog
person
medicin
reduct
cost
biolog
particularli
therapeut
protein
potenti
product
synthet
therapeut
protein
synthet
biolog
contribut
develop
person
medicin
sever
approach
import
enabl
design
discoveri
person
therapi
impact
synthet
biolog
also
discuss
variou
compon
person
medicin
pharmacogenet
term
recogn
pharmacolog
pregenom
era
studi
influenc
genet
factor
action
drug
oppos
genet
caus
diseas
genet
factor
may
major
impact
pharmacokinet
pharmacodynam
particular
drug
therebi
influenc
sensit
drug
individu
patient
certain
genotyp
pharmacogenet
threefold
role
pharmaceut
industri
relev
develop
person
medicin
studi
drug
metabol
pharmacolog
effect
predict
genet
determin
advers
reaction
drug
discoveri
develop
synthet
biolog
approach
pharmacogenet
knowledg
use
design
drug
less
advers
effect
improv
efficaci
pharmacogenom
impli
use
genet
sequenc
genom
inform
host
normal
diseas
pathogen
patient
manag
enabl
therapi
decis
pharmacogenom
import
part
person
medicin
impact
phase
drug
develop
drug
discoveri
clinic
trial
also
appli
wide
rang
therapeut
product
includ
bioengin
protein
cell
therapi
antisens
therapi
gene
therapi
synthet
biolog
use
pathway
model
improv
understand
mechan
cellular
signal
discov
new
therapeut
target
treatment
variou
diseas
import
goal
synthet
biolog
devis
molecul
regul
gene
network
programm
manner
achiev
goal
necessari
chart
sequenc
specif
natur
engin
dnabind
molecul
synthet
gene
network
design
prototyp
therapeut
circuit
impact
futur
gene
cellbas
therapi
usher
new
era
drug
discoveri
may
enabl
treatment
complex
diseas
person
manner
encycloped
inform
avail
gene
function
postgenom
era
provid
correl
system
biolog
deliv
comprehens
detail
dynam
biochem
reaction
network
live
organ
catalogu
item
reassembl
design
new
biolog
devic
system
novel
use
function
ration
systemat
manner
transgen
control
system
network
use
gene
therapi
treat
singlegen
defect
trigger
induc
express
complementari
transgen
also
use
genet
modif
bacteria
enabl
search
destroy
cancer
cell
tailor
synthet
gene
network
upload
cell
therapeut
target
bodi
endogen
network
caus
transit
diseas
healthi
state
synthet
mammalian
circuit
may
abl
function
cell
implant
could
program
sens
diseaseassoci
metabolit
produc
appropri
adjust
therapeut
respons
transgen
cell
implant
contain
prosthet
network
would
effect
transplant
genet
modifi
cell
prevent
revers
diseas
develop
selfsuffici
manner
without
repetit
treatment
synthet
multienzym
glyoxyl
shunt
use
protect
mice
highfat
diet
dietinduc
obes
shunt
prevent
complet
oxid
fatti
acid
plant
bacteria
introduc
mice
increas
fatti
acid
oxid
aptam
singlestrand
oligonucleotid
bind
given
ligand
high
affin
specif
due
particular
structur
aptamerbind
protein
versatil
power
build
block
construct
artifici
genet
switch
aptamerbas
construct
regul
tet
system
tetracyclineindepend
manner
shown
achiev
control
transgen
express
tetr
proteininhibit
aptam
enabl
rnarespons
control
tetracyclinedepend
transactiv
tta
attach
theophyllin
aptam
sensor
inhibitori
tetr
aptam
thu
tta
activ
becam
depend
ligand
sensor
aptam
aptamerbas
control
wide
use
tet
system
introduc
new
layer
regul
facilit
construct
complex
gene
network
could
also
use
safeguard
regul
gene
express
microencapsul
cell
implant
reconstruct
pathogen
dna
synthesi
use
produc
diagnost
highdens
antigen
array
use
profil
postlym
diseas
syndrom
synthesi
analysi
chimer
virus
also
made
substanti
contribut
understand
virus
respons
sever
acut
respiratori
syndrom
pandem
use
transgen
viral
strain
harbor
lethal
synthet
circuitri
may
control
insect
vector
popul
suppress
transmiss
malari
parasit
dengu
virus
similarli
synthet
home
endonucleasebas
gene
drive
system
use
spread
genet
modif
eg
resist
malaria
engin
mosquito
field
popul
advanc
sequenc
facilit
character
pathway
antibiot
biosynthesi
new
systemat
method
de
novo
biosynthet
pathway
predict
enabl
explor
metabol
chemic
space
beyond
metabol
engin
computerassist
design
modular
assembl
line
polyketid
synthas
nonribosom
peptid
synthas
may
enabl
develop
tailormad
antibiot
product
novel
antibiot
may
transfer
chosen
chassi
optim
host
factori
specif
strain
modif
advanc
metabol
engin
synthet
biolog
provid
novel
strategi
engin
antimicrobi
agent
desir
specif
sequenc
tumor
provid
consider
data
mutat
structur
variat
use
predict
individu
tumor
progress
respons
treatment
howev
predict
function
consequ
mutat
eg
phenotyp
cancer
limit
inform
genet
makeup
cancer
cell
combin
function
genom
approach
identif
novel
target
explor
rewir
cellular
pathway
key
step
toward
person
cancer
diagnost
therapi
applic
interact
gene
network
includ
synthet
biologybas
approach
futur
gene
therapi
well
util
synthet
gene
circuit
blueprint
design
stimulirespons
biohybrid
materi
recent
progress
synthet
biolog
includ
rewir
biosens
devic
bodi
endogen
network
well
novel
therapeut
approach
origin
interdisciplinari
work
gener
numer
opportun
futur
biomed
applic
research
progress
construct
minim
synthet
semisynthet
cell
bottomup
approach
encapsul
differ
macromolecul
lipid
vesicl
situ
gener
enzym
protein
prerequisit
construct
function
cell
replic
genet
materi
respond
chemic
messeng
mean
surfacemedi
receptor
liposom
studi
like
precursor
biolog
cell
complex
biochem
reaction
describ
insid
liposom
express
protein
cell
membran
inner
outer
environ
compart
specif
properti
semiperm
enabl
celltocel
commun
molecular
transport
membran
built
natur
constitu
synthet
polym
synthet
cell
could
includ
essenti
compon
person
therapi
would
cheaper
effect
tool
treatment
control
gene
express
key
stem
cell
differenti
applic
tissu
regener
cancer
therapi
stem
cell
develop
special
cell
eg
cardiomyocyt
insert
specif
sequenc
simpl
nonintegr
strategi
describ
induc
pluripot
stem
cell
ipsc
base
administr
synthet
mrna
function
mrna
transcript
four
key
gene
transcript
translat
protein
induc
pluripot
without
integr
extra
gene
genom
also
use
effici
direct
differenti
rnaipsc
termin
differenti
myogen
cell
strategi
somat
cell
reprogram
direct
cell
fate
appli
basic
research
regen
medicin
silenc
development
regul
stem
cell
reactiv
synthet
transcript
factor
interact
chromatin
rather
dna
potenti
applic
stem
cell
modifi
synthet
biolog
includ
follow
drug
screen
person
therapi
engin
stem
cell
achiev
new
function
present
bodi
introduc
back
donor
eg
cell
involv
immun
respons
program
recogn
specif
microorgan
target
effici
way
immun
system
maintain
popul
level
cell
diabet
use
autoregul
differenti
embryon
stem
cell
counterbal
autoimmun
attenu
tissu
engin
specif
desir
properti
function
synthet
microenviron
act
physic
substrat
stem
cell
attach
migrat
similar
natur
extracellular
matrix
nanofabr
technolog
shown
enabl
design
synthet
microenviron
offer
new
way
control
stem
cell
fate
eg
differenti
mesenchym
stem
cell
tissu
close
match
mechan
properti
polyacrylamid
substrat
upon
cultur
mesenchym
stem
cell
cultur
medium
stiff
gel
differenti
muscl
cell
wherea
cultur
compliant
gel
differenti
neural
cell
cultur
stiff
bonelik
gel
differenti
osteoblast
direct
develop
stem
cell
desir
cell
type
synthet
microenviron
facilit
use
person
tissu
regener
convent
vaccin
strategi
mainli
focu
liveattenu
vaccin
inactiv
microorgan
subunit
thereof
compris
purifi
compon
recombin
protein
formul
adjuv
develop
new
vaccin
limit
sever
drawback
includ
risk
associ
use
attenu
pathogen
along
difficulti
alter
vaccin
target
specif
synthet
biologybas
vaccin
aim
overcom
drawback
enabl
econom
rapid
chemic
synthesi
dna
encod
immunogen
design
silico
well
effici
assembl
deliveri
system
obtain
vector
vaccin
altogeth
synthet
biolog
help
develop
improv
vaccin
candid
consider
less
time
compar
convent
approach
exampl
given
follow
section
biocompat
well
biodegrad
nanoparticl
design
comput
model
selfassembl
singl
polypeptid
chain
produc
structur
isohedr
symmetri
diamet
nm
peptid
nanoparticl
multifunct
high
bind
affin
specif
custom
high
function
densiti
platform
use
design
produc
prototyp
malaria
vaccin
repetit
display
tandem
repeat
b
cell
immunodomin
repeat
epitop
circumsporozoit
protein
rodent
malaria
parasit
plasmodium
berghei
administ
without
adjuv
vaccin
confer
longlast
antibodi
respons
b
cell
epitop
protect
mice
malari
parasit
month
use
liposom
propos
artifici
microb
vaccin
genet
program
produc
specif
antigen
studi
mice
vaccin
show
antigenexpress
immunostimulatori
liposom
anexil
elicit
higher
specif
humor
immun
respons
produc
antigen
control
vaccin
anexil
use
synthet
biolog
platform
construct
dnabas
vaccin
combin
antigen
product
adjuv
deliveri
one
system
offer
sever
advantag
exist
vaccin
formul
system
easili
alter
antigen
simpli
chang
dna
templat
carri
risk
infect
attenu
pathogen
avail
complet
genom
sequenc
high
throughput
technolog
synthet
biolog
enabl
revers
vaccinolog
rv
avail
sequenc
data
differ
specimen
speci
pathogen
provid
opportun
select
novel
vaccin
candid
thu
empir
approach
vaccin
develop
replac
vaccin
design
rv
approach
one
power
exampl
biotechnolog
appli
field
vaccinolog
identifi
new
proteinbas
vaccin
rv
combin
avail
genom
data
analyz
capabl
new
bioinformat
tool
applic
high
throughput
express
purif
system
combin
serolog
screen
assay
coordin
screen
process
entir
genom
repertoir
bacteri
viral
parasit
pathogen
applic
rv
neisseria
meningitidi
serogroup
b
repres
first
success
novel
approach
approach
easili
appli
pathogen
vaxign
first
webbas
vaccin
design
system
predict
vaccin
target
base
genom
sequenc
use
strategi
rv
predict
featur
vaxign
pipelin
includ
protein
subcellular
locat
transmembran
helic
adhesin
probabl
conserv
human
andor
mous
protein
sequenc
exclus
genom
nonpathogen
strain
epitop
bind
mhc
class
class
ii
precomput
vaxign
databas
contain
predict
vaccin
target
genom
vaxign
also
perform
dynam
vaccin
target
predict
base
input
sequenc
vaccin
candid
e
coli
predict
use
vaxign
result
indic
vaxign
accur
effici
vaccin
design
program
discoveri
made
applic
human
genom
sequenc
alreadi
impact
practic
oncolog
influenc
design
clinic
trial
new
cancer
therapi
futur
research
cancer
expand
gener
full
genom
sequenc
variou
cancer
yield
complet
catalogu
somat
mutat
one
studi
reveal
essenti
full
repertoir
mutat
cancer
gene
enabl
us
determin
mani
combin
mutat
cancer
gene
necessari
gener
individu
cancer
sequenc
evolv
research
tool
applic
cancer
diagnost
analys
cancer
genom
well
transcriptom
applic
clinic
trial
order
exploit
full
clinic
potenti
inform
within
cancer
genom
gener
new
predictor
drug
respons
prognosi
enabl
person
manag
cancer
bacteria
synthet
engin
target
invad
destroy
cancer
cell
select
knock
specif
endogen
cancerrel
network
gene
exampl
potenti
applic
approach
brain
cancer
glioblastoma
multiform
one
challeng
cancer
effort
cure
fail
year
histori
modern
neurosurgeri
challeng
due
complet
erad
requir
cure
even
residu
cell
multipli
rapidli
recurr
tumor
kill
patient
respons
convent
treatment
surgic
resect
chemotherapi
vari
accord
characterist
individu
tumor
none
cur
one
innov
use
genet
modifi
bacteria
select
destroy
tumor
without
invad
surround
normal
brain
genet
modif
bacteria
complic
requir
select
aggress
invas
speci
extens
modif
ie
excis
harm
gene
insert
gene
select
destruct
tumor
synthet
bacteria
may
easier
construct
design
accord
characterist
individu
tumor
requir
task
better
prospect
cure
ethic
concern
percept
techniqu
synthet
biolog
use
creat
life
respons
us
presid
barack
obama
ask
presidenti
commiss
studi
bioethic
issu
review
develop
field
synthet
biolog
identifi
appropri
ethic
boundari
maxim
public
benefit
minim
risk
find
commiss
publish
decemb
recommend
detail
report
provid
publicli
account
basi
ensur
field
synthet
biolog
advanc
improv
human
health
public
welfar
process
place
identifi
assess
monitor
mitig
risk
ongo
basi
field
matur
risk
assess
preced
field
releas
product
synthet
biolog
ongo
assess
review
requir
sever
area
avoid
unnecessari
limit
scienc
social
progress
ensur
appropri
restrict
protect
individu
safeti
share
environ
ongo
dialogu
concern
regard
implic
synthet
biolog
human
speci
natur
environ
continu
synthet
biolog
develop
infanc
fulli
matur
field
scientif
inquiri
innov
synthet
biolog
stage
evolut
biotechnolog
industri
take
place
year
result
develop
commerci
product
safeti
issu
synthet
biolog
cover
exist
regul
biotechnolog
drug
synthet
biolog
alreadi
use
biotechnolog
compani
potenti
substanti
reduc
research
develop
time
product
toward
commerci
futur
synthet
biolog
product
enter
market
scientif
evid
warrant
may
need
special
regulatori
oversight
beyond
biotechnolog
product
gener
may
us
depart
defens
grant
usd
million
synthet
biolog
research
sever
univers
institut
aim
speed
bioengin
product
eight
project
fund
defens
advanc
research
project
agenc
new
initi
research
conduct
program
seek
creat
basic
product
method
tool
requir
make
bioengin
swifter
accur
design
blueprint
synthet
biolog
factori
project
pursu
initi
aim
develop
new
tool
technolog
method
enabl
rapid
develop
bioengin
product
new
materi
medicin
also
may
uk
engin
physic
scienc
research
council
http
wwwepsrcacuk
award
gbp
million
usd
million
fiveyear
grant
consortium
univers
develop
webbas
synthet
biolog
inform
system
call
synbi
current
beta
trial
synbi
host
softwar
platform
biocad
model
tool
open
possibl
undertak
highlevel
softwar
design
biopart
devic
time
uk
govern
plan
provid
boost
nation
synthet
biolog
sector
new
initi
provid
nearli
gbp
million
usd
million
research
fund
applic
fund
also
expect
consid
ethic
social
regulatori
implic
relat
use
technolog
fund
research
synthet
biolog
govern
agenc
usa
uk
encourag
accept
person
medicin
pharmaceut
industri
healthcar
profession
increas
current
research
synthet
biolog
conduct
place
usa
europ
includ
compani
usa
europ
univers
usa
europ
rest
research
institut
laboratori
number
increas
past
year
expect
continu
increas
synthet
biolog
research
market
estim
worth
usd
million
estim
grow
usd
billion
next
decad
among
new
technolog
synthet
biolog
contribut
introduct
therapeut
system
base
synthet
genom
use
expand
genet
code
design
specif
person
drug
synthesi
well
deliveri
activ
patholog
signal
improv
speed
cost
dna
synthesi
enabl
scientist
design
modifi
bacteri
chromosom
use
product
pharmaceut
intermedi
healthcar
product
synthet
mammalian
gene
networkbas
design
biohybrid
materi
use
applic
person
medicin
interact
function
synthet
biolog
may
provid
tool
devis
tailor
treatment
current
incur
condit
synthet
biolog
person
medicin
provid
commerci
opportun
biopharmaceut
industri
discoveri
person
drug
cheaper
manufactur
shorter
less
expens
develop
path
lower
failur
rate
compar
tradit
drug
although
number
ethic
issu
address
research
carri
fund
cover
investig
relev
new
ethic
issu
may
aris
synthet
biolog
remain
promis
technolog
advanc
person
medicin
